GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bullfrog AI Holdings Inc (NAS:BFRG) » Definitions » Sloan Ratio %

Bullfrog AI Holdings (Bullfrog AI Holdings) Sloan Ratio % : 0.00% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bullfrog AI Holdings Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Bullfrog AI Holdings's Sloan Ratio for the quarter that ended in Mar. 2024 was 0.00%.

As of Mar. 2024, Bullfrog AI Holdings has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Bullfrog AI Holdings Sloan Ratio % Historical Data

The historical data trend for Bullfrog AI Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bullfrog AI Holdings Sloan Ratio % Chart

Bullfrog AI Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
- - -2,352.50 -

Bullfrog AI Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bullfrog AI Holdings's Sloan Ratio %

For the Health Information Services subindustry, Bullfrog AI Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bullfrog AI Holdings's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bullfrog AI Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Bullfrog AI Holdings's Sloan Ratio % falls into.



Bullfrog AI Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Bullfrog AI Holdings's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-5.356--6.001
-0)/2.777
=23.23%

Bullfrog AI Holdings's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(-5.934--5.542
-0)/7.649
=-5.12%

Bullfrog AI Holdings's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was -1.48 (Jun. 2023 ) + -1.253 (Sep. 2023 ) + -1.297 (Dec. 2023 ) + -1.904 (Mar. 2024 ) = $-5.93 Mil.
Bullfrog AI Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was -1.228 (Jun. 2023 ) + -1.394 (Sep. 2023 ) + -1.018 (Dec. 2023 ) + -1.902 (Mar. 2024 ) = $-5.54 Mil.
Bullfrog AI Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was 0 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0 (Dec. 2023 ) + 0 (Mar. 2024 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bullfrog AI Holdings  (NAS:BFRG) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Bullfrog AI Holdings has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Bullfrog AI Holdings Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Bullfrog AI Holdings's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bullfrog AI Holdings (Bullfrog AI Holdings) Business Description

Traded in Other Exchanges
N/A
Address
325 Ellington Boulevard, Unit 317, Gaithersburg, MD, USA, 20878
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
Executives
William Enright director 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
R Don Elsey director 2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Dane R Saglio officer: Chief Financial Officer
Jason David Hanson director 8125 NORTH HAYDEN ROAD, SCOTTSDALE AZ 85258-2463
Vininder Singh director, 10 percent owner, officer: Chief Executive Officer 4 BLACK KETTLE COURT, BOYDS MD 20841